United Therapeutics Corporation Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
United Therapeutics Corp. (UTHR) PT Lowered to $106 at Cowen
October 31, 2018 12:28 PM EDTCowen analyst Chris Shibutani lowered the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $106.00 (from $110.00) while maintaining a Market Perform rating.
... MoreUnited Therapeutics (UTHR) Tops Q3 EPS by 73c, Revenues Beat
October 31, 2018 6:08 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.98, $0.73 better than the analyst estimate of $3.25. Revenue for the quarter came in at $412.7 million versus the consensus estimate of $380.43 million.
"We are pleased to see continued growth in the number of U.S. patients treated... More
